Showing results (1491-1500 of 3,190) with videos related to

Sort By:
Pageof 319
Translational Oncology|June 28, 2023
Single-cell and spatial transcriptomics reveal 5-methylcytosine RNA methylation regulators immunologically reprograms tumor microenvironment characterizations, immunotherapy response and precision treatment of clear cell renal cell carcinomaCheng-Peng Gui, Jin-Huan Wei, Chi Zhang, et al.
Translational Oncology|June 23, 2023
The human antigen R as an actionable super-hub within the network of cancer cell persistency and plasticityRastine Merat
Translational Oncology|August 6, 2023
Long noncoding RNA BBOX1-AS1 increased radiotherapy sensitivity in colorectal cancer by stabilizing and activating PFK1Qi Wang, Xiao-Fei Li, Ying-Hui Zhou, et al.
Translational Oncology|July 27, 2023
CircSLC39A8 attenuates paclitaxel resistance in ovarian cancer by regulating the miR‑185‑5p/BMF axisYuwan Liu, Zhangjin Shen, Xinyi Wei, et al.
Translational Oncology|July 29, 2023
Pan-tumor survey of RET fusions as detected by next-generation RNA sequencing identified RET fusion positive colorectal carcinoma as a unique molecular subsetMisako Nagasaka, Danielle Brazel, Yasmine Baca, et al.
Translational Oncology|July 29, 2023
Receptor-interacting protein kinase 1 (RIPK1) regulates cervical cancer cells via NF-κB-TNF-α pathway: An in vitro studyWenqi Bai, Fengjie Cui, Zihan Wang, et al.
Translational Oncology|July 24, 2023
Long non-coding RNA FENDRR suppresses cancer-associated fibroblasts and serves as a prognostic indicator in colorectal cancerFengxia Li, Jing Yang, Yankun Li, et al.
Translational Oncology|June 16, 2023
Accurate tumor purity determination is critical for the analysis of homologous recombination deficiency (HRD)Michael Menzel, Volker Endris, Constantin Schwab, et al.
Translational Oncology|June 15, 2023
Low-dose radiotherapy effects the progression of anti-tumor responseLei Gao, Anqi Zhang
Translational Oncology|June 10, 2023
E2F2 serves as an essential prognostic biomarker and therapeutic target for human renal cell carcinoma by presenting "E2F2/miR-16-5p/SPTLC1" schemaGenYi Qu, Guang Yang, Dan Chen, et al.
Pageof 319